Iovance Biotherapeutics, Inc.
$3.69B- Market cap
- $3.99B
- Debt
- +$1.00M
- Cash
- −$296.98M
Capital structure 100% equity / 0% debt · EV / Revenue 14.02x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
IOVA · current priceP/S 15.14x
$8.81Latest market snapshot
Implied fair value · at SBUX's multiple
$1.8678.8% below market
0.58 IOVA revenue / share×3.20x SBUX P/S=$1.86
Market $8.81Implied $1.86
SBUX · current priceP/S 3.20x
$104.50Latest market snapshot
Implied fair value · at IOVA's multiple
$493.99372.7% above market
32.62 SBUX revenue / share×15.14x IOVA P/S=$493.99
Market $104.50Implied $493.99